| Product Code: ETC348264 | Publication Date: Aug 2022 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | 
The India structural heart devices market import shipments demonstrated a robust growth trend with a significant CAGR from 2020 to 2024. The market exhibited accelerated growth between 2023 and 2024, indicating an expanding trajectory. Overall, the market expanded steadily, showing positive momentum and potential for further growth.
 
                            
                                                    The India structural heart devices market was estimated at US$ 39 million in 2025 and is projected to expand at a CAGR of 7.9% from 2025 to 2031 due to rising prevalence of cardiovascular diseases along with growing awareness among patients about advanced treatment options such as transcatheter aortic valve replacement (TAVR) and left ventricular assist device (LVAD) implantation procedures. Growing investments by key stakeholders including government organizations are also anticipated fuel growth during forecast period. Moreover, technological advancements have led to development of miniaturized versions which are considered beneficial for elderly population suffering from cardiac diseases. This factor will further drive industry expansion over next few years.
The India structural heart devices market is experiencing robust growth driven by several factors. Firstly, there is an increasing prevalence of cardiovascular diseases, including structural heart conditions, due to lifestyle changes, sedentary habits, and a growing aging population. Structural heart devices, such as transcatheter heart valves, septal occluders, and left atrial appendage closure devices, offer less invasive treatment options, which are gaining popularity among patients and healthcare providers. Additionally, advancements in medical technology and improved healthcare infrastructure are supporting the adoption of these devices in various cardiac procedures. Moreover, rising awareness about the benefits of early diagnosis and treatment of heart conditions is leading to higher demand for structural heart devices in India. Major players in this market, including Abbott Laboratories, Medtronic plc, Edwards Lifesciences Corporation, and Boston Scientific Corporation, are actively involved in research and development to introduce innovative and efficient devices to meet the growing demand.
The India structural heart devices market faces several challenges despite its strong growth prospects. One of the significant challenges is the high cost associated with these advanced medical devices. Structural heart devices are often expensive, making them less accessible to a large section of the population, particularly in rural areas. Affordability issues can hinder patients from accessing life-saving treatments and limit market expansion. Additionally, the lack of awareness among patients and healthcare professionals about the benefits and availability of structural heart devices can impact their adoption. Moreover, the relatively limited number of specialized healthcare centers equipped to perform complex structural heart procedures may further constrain the market`s growth. To address these challenges, market players need to focus on developing cost-effective solutions, increasing awareness through educational programs, and expanding healthcare infrastructure in underserved regions.
The India structural heart devices market experienced a notable impact from the COVID-19 pandemic. With the healthcare system focused on managing the surge of COVID-19 cases, elective procedures, including some structural heart interventions, were postponed or canceled. The reduced number of cardiac procedures during the pandemic period affected the adoption of structural heart devices. Additionally, patients` fear of visiting healthcare facilities due to infection risks and limited access to healthcare services in certain regions further contributed to the decline in structural heart device procedures. However, as the healthcare system gradually adapted to the pandemic situation, there was a resurgence in demand for structural heart procedures and devices. The need for urgent interventions and the implementation of safety protocols in healthcare facilities eventually helped the market regain momentum. Market players, including leading companies like Abbott Laboratories, Medtronic plc, Edwards Lifesciences Corporation, and Boston Scientific Corporation, continued to support healthcare providers with innovative technologies and remote monitoring solutions to ensure patient safety and improved outcomes during the pandemic.
In the India structural heart devices market, several key players play a crucial role in providing innovative and advanced medical solutions. Companies like Abbott Laboratories, Medtronic plc, Edwards Lifesciences Corporation, and Boston Scientific Corporation are among the major players in this market. These companies offer a wide range of structural heart devices, including transcatheter heart valves, septal occluders, and left atrial appendage closure devices. They invest heavily in research and development to introduce cutting-edge technologies and improve patient outcomes. Moreover, these key players collaborate with healthcare institutions and medical professionals to raise awareness about structural heart diseases and the benefits of using their devices. By continuously enhancing their product portfolios and expanding their presence in the India market, these companies are driving advancements in the field of structural heart interventions.
| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 India Structural Heart Devices Market Overview | 
| 3.1 India Country Macro Economic Indicators | 
| 3.2 India Structural Heart Devices Market Revenues & Volume, 2021 & 2031F | 
| 3.3 India Structural Heart Devices Market - Industry Life Cycle | 
| 3.4 India Structural Heart Devices Market - Porter's Five Forces | 
| 3.5 India Structural Heart Devices Market Revenues & Volume Share, By Product, 2021 & 2031F | 
| 3.6 India Structural Heart Devices Market Revenues & Volume Share, By Procedure, 2021 & 2031F | 
| 4 India Structural Heart Devices Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.2.1 Increasing prevalence of cardiovascular diseases in India | 
| 4.2.2 Growing awareness about minimally invasive procedures for heart conditions | 
| 4.2.3 Technological advancements in structural heart devices | 
| 4.3 Market Restraints | 
| 4.3.1 High cost associated with structural heart devices | 
| 4.3.2 Limited reimbursement policies for these devices in India | 
| 4.3.3 Lack of skilled healthcare professionals trained in using structural heart devices | 
| 5 India Structural Heart Devices Market Trends | 
| 6 India Structural Heart Devices Market, By Types | 
| 6.1 India Structural Heart Devices Market, By Product | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 India Structural Heart Devices Market Revenues & Volume, By Product, 2021-2031F | 
| 6.1.3 India Structural Heart Devices Market Revenues & Volume, By Herat Valve Devices, 2021-2031F | 
| 6.1.4 India Structural Heart Devices Market Revenues & Volume, By Surgical Heart Valves, 2021-2031F | 
| 6.1.5 India Structural Heart Devices Market Revenues & Volume, By Transcatheter Heart Valves, 2021-2031F | 
| 6.1.6 India Structural Heart Devices Market Revenues & Volume, By Occluders and Delivery Systems, 2021-2031F | 
| 6.1.7 India Structural Heart Devices Market Revenues & Volume, By Annuloplasty Rings, 2021-2031F | 
| 6.1.8 India Structural Heart Devices Market Revenues & Volume, By Other Devices, 2021-2031F | 
| 6.2 India Structural Heart Devices Market, By Procedure | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 India Structural Heart Devices Market Revenues & Volume, By Replacement Procedures, 2021-2031F | 
| 6.2.3 India Structural Heart Devices Market Revenues & Volume, By TAVR Procedures, 2021-2031F | 
| 6.2.4 India Structural Heart Devices Market Revenues & Volume, By SAVR Procedures, 2021-2031F | 
| 6.2.5 India Structural Heart Devices Market Revenues & Volume, By Repair Procedures, 2021-2031F | 
| 6.2.6 India Structural Heart Devices Market Revenues & Volume, By Closure Procedures, 2021-2031F | 
| 6.2.7 India Structural Heart Devices Market Revenues & Volume, By Annuloplasty, 2021-2031F | 
| 6.2.8 India Structural Heart Devices Market Revenues & Volume, By TMVR Procedures, 2021-2031F | 
| 6.2.9 India Structural Heart Devices Market Revenues & Volume, By TMVR Procedures, 2021-2031F | 
| 7 India Structural Heart Devices Market Import-Export Trade Statistics | 
| 7.1 India Structural Heart Devices Market Export to Major Countries | 
| 7.2 India Structural Heart Devices Market Imports from Major Countries | 
| 8 India Structural Heart Devices Market Key Performance Indicators | 
| 8.1 Adoption rate of minimally invasive procedures for structural heart conditions | 
| 8.2 Number of hospitals offering structural heart devices procedures | 
| 8.3 Success rate of procedures using structural heart devices | 
| 8.4 Patient satisfaction and outcomes post structural heart devices procedures | 
| 9 India Structural Heart Devices Market - Opportunity Assessment | 
| 9.1 India Structural Heart Devices Market Opportunity Assessment, By Product, 2021 & 2031F | 
| 9.2 India Structural Heart Devices Market Opportunity Assessment, By Procedure, 2021 & 2031F | 
| 10 India Structural Heart Devices Market - Competitive Landscape | 
| 10.1 India Structural Heart Devices Market Revenue Share, By Companies, 2024 | 
| 10.2 India Structural Heart Devices Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |